Zhejiang Orient Gene Biotech Co., Ltd (Orient Gene), a gene therapy-focused biotech products manufacturer, made a stellar debut on the Shanghai Stock Exchange STAR Market with its scrip soaring 328 per cent and its market cap exceeding 11 billion yuan ($1.6 billion) in opening trade on Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
